The FDA on Friday issued a warning for people with diabetes and their health care providers cautioning against the use of diabetes management devices that have not been fully evaluated and are not yet available for purchase in the United States.
With a focus on unauthorized continuous glucose monitoring systems, insulin pumps and automated insulin dosing systems, as well as the use of these unauthorized devices in combination with those that have received approval, the FDA noted that users could potentially suffer due to improper insulin doses and faulty glucose level measures.
Focus On: Physician Burnout
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.